This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Church & Dwight Likely to Keep Gaining on Solid Sales Trend
by Zacks Equity Research
Church & Dwight's (CHD) sales are gaining from continued category growth and healthy market share gains. The company's consumer international business has long been contributing to the top line.
Prestige Consumer (PBH) Stock Down Despite Q1 Earnings Beat
by Zacks Equity Research
Prestige Consumer (PBH) delivers better-than-expected fiscal Q1 results, driven by solid consumption trends. However, both earnings and sales fall year over year.
Clorox (CLX) Q4 Earnings Top Estimates, Soft View Hurts Stock
by Zacks Equity Research
Clorox (CLX) reports mixed fourth-quarter fiscal 2019 results. Lower taxes and gross margin expansion aid its earnings while lower volume and unfavorable currency hurt sales.
Church & Dwight (CHD) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Church & Dwight's (CHD) earnings and sales improve in Q2, backed by gains from most product categories.
Church & Dwight (CHD) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 9.62% and 0.54%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Buy Procter & Gamble (PG) After Q4 Earnings Report?
by Christopher Vargas
Procter & Gamble (PG) reported its fiscal 2019 Q4 earnings before the opening bell on Tuesday.
Procter & Gamble (PG) Stock Up on Q4 Earnings & Sales Beat
by Zacks Equity Research
Procter & Gamble (PG) posts robust fourth-quarter fiscal 2019 results. Also, the company provided upbeat guidance for fiscal 2020.
What Awaits Corteva (CTVA) in its Debut Q2 Earnings Report?
by Zacks Equity Research
Digital efforts and product innovation are likely to benefit Corteva's (CVTA) second-quarter 2019 results. Further, it will gain from momentum in the seeds market.
Can Cost and Tariff Woes Mar Clorox's (CLX) Earnings in Q4?
by Zacks Equity Research
Clorox's (CLX) fourth-quarter fiscal 2019 results are likely to bear impacts of higher commodity costs, adverse currency, increased manufacturing and logistics expenses, and tariffs.
Why Archer Daniels' (ADM) Q2 Earnings Are Likely to Fall Y/Y
by Zacks Equity Research
Archer Daniels' (ADM) soft Carbohydrate Solutions unit due to impacts of adverse weather conditions, lower ethanol volumes and issues at Decatur complex is likely to hurt second-quarter 2019 results.
Will Cost Woes Hurt B&G Foods (BGS) This Earnings Season?
by Zacks Equity Research
Input costs related to freight and warehousing are likely to dent B&G Foods' (BGS) Q2 performance. Also, the Pirate Brands' divestiture is likely to dent sales.
Colgate (CL) Q2 Earnings & Sales Miss Estimates, Decline Y/Y
by Zacks Equity Research
Colgate (CL) posts lower-than-expected second-quarter 2019 results. Foreign currency translations remain a major headwind in the quarter.
Church & Dwight (CHD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Organic Sales to Boost Church & Dwight's (CHD) Q2 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter 2019 results are likely to gain from organic sales growth and prudent pricing moves.
What's in the Offing for Mondelez's (MDLZ) Q2 Earnings?
by Zacks Equity Research
Mondelez's (MDLZ) Q2 earnings to gain from saving efforts. However, high input costs and adverse currency rates are concerns.
Things You Need to Know Before AB InBev's (BUD) Q2 Earnings
by Zacks Equity Research
AB InBev (BUD) is poised for growth in second-quarter 2019, owing to strong sales trend and persistent strength in global brands. However, weakness in some markets and soft beer volume may affect results.
Check Out Colgate's (CL) Probability to Beat in Q2 Earnings
by Zacks Equity Research
Colgate's (CL) growth efforts indicate that it will likely retain the robust bottom-line surprise trend. However, soft margins and adverse currency may be deterrents.
Colgate's (CL) Growth Efforts Well on Track Amid Soft Margins
by Zacks Equity Research
Colgate's (CL) strong surprise trend, higher pricing, strong innovation and expansion efforts bode well. However, high input costs and currency headwinds concerns.
Soap & Cleaning Materials Industry Outlook Upbeat on New Products
by Rajani Lohia
The FMCG space is likely to gain from investment in brands, innovation, cost-containment and pricing actions. However, its struggles against higher raw material and transportation costs continue.
3 Reasons Why Church & Dwight (CHD) Is a Hot Investment Pick
by Zacks Equity Research
Church & Dwight (CHD) is gaining on the back of strong organic sales trend, buyouts, focus on international business, product innovations and portfolio expansion.
Clorox (CLX) Stock Loses Sheen: What's Hindering its Growth?
by Zacks Equity Research
Clorox (CLX) expects gross margin to be flat in fiscal 2019 as gains from higher prices and cost-savings efforts are likely to be offset by higher costs and adverse currency rates.
Church & Dwight Sales to Gain on International Unit & More
by Zacks Equity Research
Church & Dwight's (CHD) top line has been impressive for a while, gaining from strong Consumer International unit, buyouts and innovation.
Why Is Church & Dwight (CHD) Up 0.3% Since Last Earnings Report?
by Zacks Equity Research
Church & Dwight (CHD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clorox (CLX) Boosts Shareholder Value With 10% Dividend Hike
by Zacks Equity Research
Clorox (CLX) enhances shareholder returns by a 10% hike in its quarterly dividend.
4 Factors That Make Church & Dwight (CHD) a Promising Stock
by Zacks Equity Research
Church & Dwight (CHD) is committed toward boosting gross margin through pricing. Also, it boasts a splendid sales surprise history.